Lupin SWOT Analysis
Here is a detailed SWOT analysis of Lupin covering strengths, weaknesses, opportunities and threats.
Lupin Strengths
- World wide leader in Cephalosporin and Anti TB drugs
- Considerable presence in market for drugs against Asthma, Pediatrics, Diabetes, and CNS boosts the sales
- In the US and Japanese market it is the largest generic player
- Acquisition of I’rom pharma helped to increase its product list and in turn sales
- Wide global footprint as it is present in over 70 countries
Above are the strengths in the SWOT Analysis of Lupin. The strengths of Lupin looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Lupin Weaknesses
- High dependence on global formulation business with 84% revenue coming from US market
- Forecasting done on technological level is less
- It operates in low growth segments such CNS, respiratory diseases
These were the weaknesses in the Lupin SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Lupin Opportunities
- Increased health awareness
- Emerging technological trends in drug delivery
- Increasing prevalence of TB in developing countries
Above we covered the opportunities in Lupin SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Read more about Lupin
Lupin Threats
- Unsuccessfulassimilation of questions
- Rigid opposition both from locals and global company
- Soaring cost of discovering novel products
The threats in the SWOT Analysis of Lupin are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Lupin SWOT analysis.
Read Similar SWOT analysis
About Lupin
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Lupin Overview | |
|---|---|
| Parent Company |
Lupin |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Being lupin, enriching lives everyday |
| USP |
Lupin is the world’s largest manufacturer of anti- tuberculosis drugs |
| Lupin STP | |
| Segmentation |
Anti TB segment, Cardiovascular, Oral and injectable, pediatric products API’s, Anti-Infectives segment |
| Target Market |
Healthcare professionals, doctors treating patients suffering from TB, respiratory & cardiovascular diseases |
| Positioning |
It is innovation led pharmaceutical company, which specializes in generic, API & branded formulations for developed & developing world. |
Browse marketing analysis of more brands and companies similar to Lupin. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
